01st week of 2020 patent applcation highlights part 24 |
Patent application number | Title | Published |
20200002309 | HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS | 2020-01-02 |
20200002310 | SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | 2020-01-02 |
20200002311 | PYRAZOLYL-UREAS AS KINASE INHIBITORS | 2020-01-02 |
20200002312 | ASK1 ISOINDOLIN-1-ONE INHIBITORS AND METHODS OF USE THEREOF | 2020-01-02 |
20200002313 | QUINOLINE DERIVATIVE | 2020-01-02 |
20200002314 | NOVEL BENZIMIDAZOLE DERIVATIVES | 2020-01-02 |
20200002315 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | 2020-01-02 |
20200002316 | SOLID FORMS COMPRISING (1E, 4E)-2-AMINO-N,N-DIPROPYL-8-(4-(PYRROLIDINE-1-CARBONYL)PHENYL)-3H-BENZO[B]- AZEPINE-4-CARBOXAMIDE, COMPOSITIONS THEREOF, AND USES THEREOF | 2020-01-02 |
20200002317 | CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN | 2020-01-02 |
20200002318 | AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS | 2020-01-02 |
20200002319 | 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | 2020-01-02 |
20200002320 | COMPOUND USEFUL TO TREAT MYCOSES | 2020-01-02 |
20200002321 | OXAZOLIDINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATING BACTERIAL INFECTIONS, INCLUDING INFECTION OF MYCOBACTERIUM TUBERCULOSIS | 2020-01-02 |
20200002322 | NOVEL COMPOUND, FLUORESCENCE DERIVATIZATION REAGENT INCLUDING SAID NOVEL COMPOUND, METHOD FOR OPTICALLY RESOLVING OPTICAL ISOMER OF AMINO ACID IN WHICH SAID NOVEL COMPOUND IS USED, AND FLUORESCENCE DERIVATIZED AMINO ACID | 2020-01-02 |
20200002323 | COMPOUNDS | 2020-01-02 |
20200002324 | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE | 2020-01-02 |
20200002325 | PROCESS FOR MAKING HEPATITIS B CORE PROTEIN MODULATORS | 2020-01-02 |
20200002326 | SULFOXIMINE GLYCOSIDASE INHIBITORS | 2020-01-02 |
20200002327 | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | 2020-01-02 |
20200002328 | PHARMACEUTICAL COMPOUNDS | 2020-01-02 |
20200002329 | CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUANTERNARY AMMONIUM SALT STRUCTURE | 2020-01-02 |
20200002330 | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | 2020-01-02 |
20200002331 | SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHEN- YL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPR- OPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE | 2020-01-02 |
20200002332 | INHIBITING CREB BINDING PROTEIN (CBP) | 2020-01-02 |
20200002333 | FUNGICIDAL COMPOSITIONS | 2020-01-02 |
20200002334 | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN | 2020-01-02 |
20200002335 | IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS | 2020-01-02 |
20200002336 | BICYCLIC COMPOUNDS AS ATX INHIBITORS | 2020-01-02 |
20200002337 | DIHYDROPYRIDOPHTHALAZINONE COMPOUNDS AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) FOR TREATMENT OF DISEASES AND METHOD OF USE THEREOF | 2020-01-02 |
20200002338 | SALTS OF AN FGFR INHIBITOR | 2020-01-02 |
20200002339 | COMPOSITIONS AND METHODS FOR MAKING TERPENOID INDOLE ALKALOIDS | 2020-01-02 |
20200002340 | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | 2020-01-02 |
20200002341 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | 2020-01-02 |
20200002342 | PYRROLO[3,2-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | 2020-01-02 |
20200002343 | Crystalline Form of Ribociclib Succinate | 2020-01-02 |
20200002344 | SYNTHESIS OF COELENTERAZINE | 2020-01-02 |
20200002345 | PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2020-01-02 |
20200002346 | PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | 2020-01-02 |
20200002347 | MACROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | 2020-01-02 |
20200002348 | HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS | 2020-01-02 |
20200002349 | 2-HYDROCARBYL-3-(DIHYDROXYFLUORESCEINYL)PHTHALIMIDINE MONOMERS, METHODS OF MANUFACTURE, AND COPOLYMERS DERIVED THEREFROM | 2020-01-02 |
20200002350 | POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS | 2020-01-02 |
20200002351 | Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration | 2020-01-02 |
20200002352 | PALLADIUM-MEDIATED KETOLIZATION | 2020-01-02 |
20200002353 | HETEROARYL ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | 2020-01-02 |
20200002354 | HEXAHYDROPYRAZINOBENZ- OR -PYRIDO-OXAZEPINES CARRYING AN OXYGEN-CONTAINING SUBSTITUENT AND USE THEREOF IN THE TREATMENT OF 5-HT2C-DEPENDENT DISORDERS | 2020-01-02 |
20200002355 | PRMT5 INHIBITORS | 2020-01-02 |
20200002356 | POLYMORPHIC MIXTURE OF RIFAXIMIN AND ITS USE FOR THE PREPARATION OF SOLID FORMULATIONS | 2020-01-02 |
20200002357 | POLYMORPHIC MIXTURE OF RIFAXIMIN AND ITS USE FOR THE PREPARATION OF SOLID FORMULATIONS | 2020-01-02 |
20200002358 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | 2020-01-02 |
20200002359 | NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES | 2020-01-02 |
20200002360 | METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | 2020-01-02 |
20200002361 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2020-01-02 |
20200002362 | DIFLUOROMETHYL AND DIFLUOROMETHYLENE TRANSFER REAGENTS | 2020-01-02 |
20200002363 | COMPOUNDS CONTAINING SI ATOMS FOR OPTICALLY ACTIVE DEVICES | 2020-01-02 |
20200002364 | WATER-SOLUBLE ACETAMINOPHEN ANALOGS | 2020-01-02 |
20200002365 | PHOSPHORUS-CONTAINING COMPOUND, PHOSPHORUS-CONTAINING FLAME RETARDANT, PREPARATION METHOD THEREOF, AND ARTICLE MADE THEREFROM | 2020-01-02 |
20200002366 | CYTOTOXIC PLATINUM COMPLEX, ITS PREPARATION AND THERAPEUTIC USE | 2020-01-02 |
20200002367 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD | 2020-01-02 |
20200002368 | AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX | 2020-01-02 |
20200002369 | PROCESS FOR PREPARATION OF REGADENOSON AND POLYMORPHS THEREOF | 2020-01-02 |
20200002370 | Novel Compounds | 2020-01-02 |
20200002371 | OXYSTEROLS AND METHODS OF USE THEREOF | 2020-01-02 |
20200002372 | AMINOSTEROID DERIVATIVES AND PROCESS FOR PRODUCING SAME | 2020-01-02 |
20200002373 | SYSTEMS AND METHODS FOR PREPARING A POLYPEPTIDE FROM A MIXTURE | 2020-01-02 |
20200002374 | IMPROVED PROCESS FOR THE PREPARATION OF A DODECAPEPTIDE | 2020-01-02 |
20200002375 | DUAL MASS SPECTROMETRY-CLEAVABLE CROSSLINKING REAGENTS FOR PROTEIN-PROTEIN INTERACTIONS | 2020-01-02 |
20200002376 | MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE | 2020-01-02 |
20200002377 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | 2020-01-02 |
20200002378 | Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer | 2020-01-02 |
20200002379 | AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE | 2020-01-02 |
20200002380 | MODULATION OF COMPLEMENT ACTIVITY | 2020-01-02 |
20200002381 | SCORPION VENOM HEAT-RESISTANT SYNTHETIC PEPTIDE AND APPLICATIONS THEREOF | 2020-01-02 |
20200002382 | Method for manufacturing oxytocin by liquid-phase polypeptide synthesis | 2020-01-02 |
20200002383 | COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE CH235 LINEAGE ANTIBODIES | 2020-01-02 |
20200002384 | MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN | 2020-01-02 |
20200002385 | Virus-Like Particle | 2020-01-02 |
20200002386 | MODIFIED AAV CAPSID PROTEINS AND USES THEREOF | 2020-01-02 |
20200002387 | CD20-BINDING IMMUNOTOXINS FOR INDUCING CELLULAR INTERNALIZATION AND METHODS USING SAME | 2020-01-02 |
20200002388 | Mating Factor Alpha Pro-Peptide Variants | 2020-01-02 |
20200002389 | TRANSDERMAL PEPTIDE WITH NUCLEAR LOCALIZATION ABILITY AND USE THEREOF | 2020-01-02 |
20200002390 | HTT REPRESSORS AND USES THEREOF | 2020-01-02 |
20200002391 | COMPLEMENT FACTOR BASED AFFINITY CHROMATOGRAPHY | 2020-01-02 |
20200002392 | TREATMENT OF RETINITIS PIGMENTOSA | 2020-01-02 |
20200002393 | METHOD OF MANAGING JOINT PAIN | 2020-01-02 |
20200002394 | HDM-2 TARGETING COMPOSITIONS CAUSE TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS | 2020-01-02 |
20200002395 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS | 2020-01-02 |
20200002396 | PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, GRANULOCYTE-COLONY STIMULATING FACTOR MUTANT PROTEIN OR TRANSFERRIN FUSION PROTEIN THEREOF | 2020-01-02 |
20200002397 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | 2020-01-02 |
20200002398 | De Novo Design of Potent and Selective Interleukin Mimetics | 2020-01-02 |
20200002399 | METHOD OF IDENTIFYING MALODOR MODULATING COMPOUNDS | 2020-01-02 |
20200002400 | CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF | 2020-01-02 |
20200002401 | CD44 BINDING PEPTIDES | 2020-01-02 |
20200002402 | CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF | 2020-01-02 |
20200002403 | SYNTHETIC LIBRARY OF SPECIFIC BINDING MOLECULES | 2020-01-02 |
20200002404 | HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OF NECROTIC ENTERITIS IN POULTRY | 2020-01-02 |
20200002405 | ARENAVIRUS MONOCLONAL ANTIBODIES AND USES | 2020-01-02 |
20200002406 | HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA B NEURAMINIDASE | 2020-01-02 |
20200002407 | ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS | 2020-01-02 |
20200002408 | RECOMBINANT GRAM NEGATIVE BACTERIA AND METHODS OF GENERATING AND UTILIZING SAME | 2020-01-02 |